From: The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®
La expression (compared to healthy tissue)
Survival status
Number per group
Dead
Alive
>2-fold increase
103 (61%)
65 (39%)
168
<2-fold increase
133 (48%)
142 (52%)
275